1336912-68-5

Basic information

• Product Name: (S)-tert-Butyl 1-ethylpyrrolidin-3-ylcarbamate
• Synonyms: (S)-tert-Butyl 1-ethylpyrrolidin-3-ylcarbamate
• CAS NO: 1336912-68-5
• Molecular Formula: C11H22N2O2
• Molecular Weight: 214.30458
• Mol File: 1336912-68-5.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (S)-tert-Butyl 1-ethylpyrrolidin-3-ylcarbamate(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-tert-Butyl 1-ethylpyrrolidin-3-ylcarbamate(1336912-68-5)
• EPA Substance Registry System: (S)-tert-Butyl 1-ethylpyrrolidin-3-ylcarbamate(1336912-68-5)

Safety Data

• Hazardous Substances Data: 1336912-68-5(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
(S)-tert-Butyl 1-ethylpyrrolidin-3-ylcarbamate is used as a reagent in organic synthesis for its ability to facilitate the creation of various bioactive compounds. Its unique structure and properties make it a versatile component in the synthesis of complex organic molecules.
Used in Pharmaceutical Production:
In the pharmaceutical industry, (S)-tert-Butyl 1-ethylpyrrolidin-3-ylcarbamate is used as a building block for the production of drugs. Its chirality and structural characteristics contribute to the development of novel pharmaceuticals with enhanced efficacy and selectivity.
Used in Asymmetric Synthesis:
(S)-tert-Butyl 1-ethylpyrrolidin-3-ylcarbamate is used as a key component in asymmetric synthesis, where its specific spatial arrangement of atoms is crucial for achieving the desired outcome. This application is particularly relevant in the development of enantiomerically pure compounds, which are essential in various pharmaceutical and chemical applications.
Used in Research and Development:
(S)-tert-Butyl 1-ethylpyrrolidin-3-ylcarbamate is also used as a subject of research in the field of pharmacology, where its potential properties and applications are being explored. The findings from these studies may lead to the discovery of new medical uses for (S)-tert-Butyl 1-ethylpyrrolidin-3-ylcarbamate, further expanding its utility and relevance in the scientific community.

Upstream product

• 75-03-6 ethyl iodide 
• 122536-76-9 3(S)-(tert-butoxycarbonylamino)pyrrolidine 

Downstream Products

• 216667-65-1 (S)-1-ethylpyrrolidin-3-ylamine 
• 1412976-93-2 methyl (1aRS,7bSR)-5-{2-[((S)-1-ethylpyrrolidin-3-ylcarbamoyl)methyl]-4-fluorobenzenesulfonylamino}-1,1a,2,7b-tetrahydrocyclopropa[c]chromene-4-carboxylate 
• 1412974-65-2 (1aRS,7bSR)-5-{2-[((S)-1-ethylpyrmlidin-3-ylcarbamoyl)methyl]-4-fluoro-benzenesulfonylamino}-1,1a,2,7b-tetrahydrocyclopropa[c]chromene-4-carboxylic acid 
• 1412974-65-2 (1aRS,7bSR)-5-{2-[((S)-1-ethylpyrrolidin-3-ylcarbamoyl)methyl]-4-fluoro-benzenesulfonylamino}-1,1a,2,7b-tetrahydrocyclopropa[c]chromene-4-carboxylic acid 
• 1412976-93-2 methyl (1aRS,7bSR)-5-{2-[((S)-1-ethylpyrrolidin-3-ylcarbamoyl)methyl]-4-fluorobenzenesulfonylamino}-1,1a,2,7b-tetrahydrocyclopropa[c]chromene-4-carboxylate 

Relevant articles and documents

METHODS OF TREATING LIVER DISEASES

The invention provides tricyclic compounds and their use in treating liver disorders, such as non-alcoholic steatohepatitis and related disorders (e.g., fibrosis). The compounds are contemplated to have activity against methionyl aminopeptidase 2.

PARTIALLY SATURATED TRICYCLIC COMPOUNDS AND METHODS OF MAKING AND USING SAME

The invention provides tricyclic compounds and their use in treating medical disorders, such as obesity. Pharmaceutical compositions and methods of making various tricyclic compounds are provided. The compounds are contemplated to have activity against methionyl aminopeptidase 2.

PHENYL SULFONYL DERIVATIVES AND THEIR USE AS HISTAMINE H3 ANTAGONISTS

A compound having the formula (1) wherein W represents N or CH; R1 represents H or C1-3 alkyl; R2 represents a N-containing heterocyclyl ring or a -C1-3 alkylene-N-containing heterocyclyl group; in which any N-c